Navigation Links
Plaintiff Furnishes Witness List for First Trial in DePuy ASR Multidistrict Litigation, Reports Parker Waichman LLP
Date:8/15/2013

(PRWEB) August 15, 2013

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective medical devices, reports that, based on a document filed on Aug. 12, 2013, in the District Court, Northern District of Ohio, the Plaintiff in the first bellwether case in the lawsuit entitled: In Re DePuy Orthopaedics, Inc., ASR Hip Implant Products Liability Litigation (MDL 2197) has identified 95 witnesses who could be called to testify on her behalf. The trial is slated to begin on Sept. 9, 2013 (McCracken v. DePuy Orthopaedics Inc., et al., Case No. 1:11-dp-20485).

Plaintiff Ann McCracken was implanted with the DePuy ASR metal hip on or around Aug. 24, 2009, and alleges that, as a result of the procedure, she suffered and continues to suffer serious bodily injury and was forced to undergo revision surgery on or around Jan. 17, 2011, according to court documents. McCracken resides in Rochester, New York.

“Considering the kinds of injuries these metal-on-metal hip implants are alleged to have caused, it is important that we continue moving forward,” said Daniel C. Burke, Senior Litigation Counsel at Parker Waichman LLP.

According to information posted on Jan. 17, 2013, by the U.S. Food and Drug Administration(FDA), those with metal hip implants may experience adverse events after surgery, including:

  •     Hip dislocation, when the ball of the thighbone (femur) slips out of its socket in the hip bone (pelvis)
  •     Bone fracture
  •     Joint infection
  •     Local nerve damage with numbness/weakness
  •     Device loosening or breakage
  •     Difference in leg lengths
  •     Bone loss (osteolysis)

The FDA also noted that patients should be aware of potential symptoms that may occur three or more months after surgery, including:

  •     Pain in the groin, hip or leg
  •     Swelling at or near the hip joint
  •     A limp or change in walking ability
  •     Noise (popping, grinding, clicking or squeaking) from the hip joint

DePuy’s ASR and other metal-on-metal hip implants were approved via the 510(k) route, which exempts devices from clinical testing as long as the manufacturers show that their product is similar to a previous device already on the market. The FDA reported on Jan. 18, 2013, that it was attempting to change the 510(k) approval process; the agency has proposed that all-metal hip replacements go through premarket approval, which would require device makers to prove that their products are safe and effective.

A March 8, 2013, Bloomberg article noted that Johnson & Johnson, DePuy’s parent company, recalled 93,000 ASR hips in 2010, citing a failure rate of 12 percent in five years. In Australia, failure rates have exceeded 40 percent in seven years, Bloomberg reported.

Parker Waichman LLP continues to offer free legal consultations to victims of injuries allegedly caused by DePuy ASR and other metal-on-metal hip implants. If you or a loved one experienced premature failure of your implant or other health problems associated with a recalled DePuy ASR hip implant or other metal-on-metal hip implant, please contact their office by visiting the firm's DePuy ASR hip implant injury page at yourlawyer.com. Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636).

Contact:
Parker Waichman LLP
Gary Falkowitz, Managing Attorney
(800) LAW-INFO
(800) 529-4636
yourlawyer.com

Read the full story at http://www.prweb.com/releases/DePuyASR_McCracken/08/prweb11032815.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. The US Drug Watchdog Now Urges Plaintiffs Law Firms Worldwide To Contact Them About A Possible International Effort To Help Victims Of Defective Drugs Or Medical Devices
2. US Drug Watchdog Now Offers Victims Of A Transvaginal Mesh Product Failure A Unequaled Service By Offering the Names of Top Plaintiffs Attorneys-Who are all also Women
3. Skechers Lawsuit Filed by Wright & Schulte, Utah Plaintiff Allegedly Suffered Serious Ankle Injuries Due to Shape-Ups Defective Design
4. US Drug Watchdog Now Urges Transvaginal Mesh, Tape, or Bladder Sling Failure Victims To Call Them For the Names of Top Plaintiffs Women Attorneys--Erosion Is Not Normal
5. Skechers Lawsuit Filed On Behalf of Ohio Woman, Alleging That the Defective Design of Shape-Ups Caused the Plaintiff’s Serious Knee Injuries, by Wright & Schulte
6. Skechers Injury Lawsuit Update: Richard W. Schulte, Partner with Wright & Schulte LLC, Appointed to Plaintiffs’ Steering Committee in California Skechers Toning Shoes Litigation
7. Imprelis Class Action Lawsuit Plaintiffs Could See Settlement Soon, Clients Can Opt-Out If Settlement Is Insufficient, Reports Wright & Sculte LLC
8. NuvaRing Lawsuits Move Forward, as Federal Judge Rules that Plaintiffs’ Experts May Testify on “Bursts” of Estrogen Allegedly Delivered by NuvaRing, Wright & Schulte LLC
9. The National Plaintiff’s Law Firm of Baron and Budd Handling Granuflo Recall Lawsuits
10. Mirena IUD Lawyers at Gilman Law LLP, a Leading Pharmacy Law and Defective Drug Plaintiffs’ Law Firm, Anticipates Progress in Newly Established Mirena Federal Litigation
11. Byetta Lawyers at Gilman Law, a Leading Pharmacy Law and Defective Drug Plaintiffs’ Law Firm, Troubled by Growing Byetta Pancreatic Cancer Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... (PRWEB) , ... April 26, ... ... which provides an agile ecosystem and domain expertise for sponsors and CROs ... randomization and trial supply management (RTSM) software platform. Bioclinica AGILE RTSM ...
(Date:4/25/2017)... ... 25, 2017 , ... Bellus Medical, a leader in medical ... new class of photodynamic cosmetics (PDC). , Allumera® is the first PDC cream ... of aging, and minimize the appearance of pores – all with minimal downtime ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... they have signed an agreement to be the preferred physical therapy provider for ... and returning them to Derby City CrossFit as quickly and effectively as possible, ...
(Date:4/25/2017)... ... April 25, 2017 , ... A stressful work environment ... can also decrease overall productivity and performance in the workplace. The goal of Clearview ... the last few weeks of April, Clearview Resolution Services will be shutting down the ...
(Date:4/25/2017)... ... April 25, 2017 , ... A recent report from the ... for the 2015-16 school year across Wisconsin’s public schools, charter schools, and private ... patterns in student test score performance, the report’s limited analyses fail to provide ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017  New research provides evidence that an old drug ... a study released today that will be presented at the ... Boston , April 22 to 28, 2017. ... Parkinson,s disease, the oral drug levodopa has long been considered ... as the disease progresses, the effects of the medication can ...
(Date:4/19/2017)... THOUSAND OAKS, Calif. , April 19, 2017 ... premium industrial buildings it is developing at Conejo ... California , to Atara Biotherapeutics, Inc. ... patients with severe and life-threatening diseases that have ... focus on allogeneic T-cell therapies for cancer, autoimmune ...
(Date:4/18/2017)... MINNEAPOLIS , April 18, 2017 Cogentix ... focused on providing the Urology, Uro/Gyn and Gynecology markets ... for the first quarter ended March 31, 2017 after ... The Company will host a conference call ... day on Tuesday, May 2, 2017 at 4:30 p.m. ...
Breaking Medicine Technology: